Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains
Related Experiment Video
Updated: Feb 24, 2026

Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
Nicolas Privat1,2,3, Etienne Levavasseur1,2,3, Serfildan Yildirim1,2,3
1From the INSERM, UMR S1127, 75013 Paris, France.
Abstract:
Human prion diseases such as Creutzfeldt-Jakob disease are transmissible brain proteinopathies, characterized by the accumulation of a misfolded isoform of the host cellular prion protein (PrP) in the brain. According to the prion model, prions are defined as proteinaceous infectious particles composed solely of this abnormal isoform of PrP (PrPSc). Even in the absence of genetic material, various prion strains can be propagated in experimental models. They can be distinguished by the pattern of disease they produce and especially by the localization of PrPSc deposits within the brain and the spongiform lesions they induce. The mechanisms involved in this strain-specific targeting of distinct brain regions still are a fundamental, unresolved question in prion research. To address this question, we exploited a prion conversion in vitro assay, protein misfolding cyclic amplification (PMCA), by using experimental scrapie and human prion strains as seeds and specific brain regions from mice and humans as substrates. We show here that region-specific PMCA in part reproduces the specific brain targeting observed in experimental, acquired, and sporadic Creutzfeldt-Jakob diseases. Furthermore, we provide evidence that, in addition to cellular prion protein, other region- and species-specific molecular factors influence the strain-dependent prion conversion process. This important step toward understanding prion strain propagation in the human brain may impact research on the molecular factors involved in protein misfolding and the development of ultrasensitive methods for diagnosing prion disease.
Insights
Prion diseases involve misfolded prion proteins (PrPSc) accumulating in the brain. This study reveals that specific brain regions and other molecular factors influence how different prion strains target and propagate within the brain.
Area of Science:
- Neuroscience
- Molecular Biology
- Infectious Diseases
Background:
- Human prion diseases, like Creutzfeldt-Jakob disease, are fatal neurodegenerative disorders caused by misfolded prion proteins (PrPSc).
- Prion strains exhibit distinct patterns of brain deposition and lesion induction, but the mechanisms of this region-specific targeting remain unclear.
- Understanding prion propagation is crucial for diagnosing and potentially treating these diseases.
Purpose of the Study:
- To investigate the molecular mechanisms underlying prion strain-specific targeting of distinct brain regions.
- To determine if prion conversion assays can replicate observed strain-specific brain tropism.
- To identify potential co-factors influencing prion propagation in a region- and species-specific manner.
Main Methods:
- Utilized protein misfolding cyclic amplification (PMCA), an in vitro prion conversion assay.
- Employed experimental scrapie and human prion strains as seeds.
- Used specific mouse and human brain regions as substrates for PMCA.
Main Results:
- Region-specific PMCA partially reproduced the brain targeting patterns observed in various Creutzfeldt-Jakob disease models.
- Demonstrated that factors beyond the prion protein itself influence strain-dependent prion conversion.
- Identified region- and species-specific molecular factors affecting prion propagation.
Conclusions:
- Prion propagation and brain targeting are influenced by both prion strain properties and host-specific molecular factors.
- This research provides insights into the molecular basis of prion tropism within the human brain.
- Findings may aid in developing ultrasensitive diagnostic tools for prion diseases and understanding protein misfolding disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Subviral Agents

